This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2024 Jul 10;110(15):1005-1014.

doi: 10.1136/heartjnl-2023-322928.

Atherosclerotic cardiovascular disease risk prediction: current state-of-the-art

Amit Rout¹, Sanchit Duhan², Muhammad Umer¹, Miranda Li³, Dinesh Kalra⁴

Affiliations

Affiliations

¹ Cardiology, University of Louisville, Louisville, Kentucky, USA.
² Cardiology, Sinai Health System, Baltimore, Maryland, USA.
³ Cardiology, University of Washington School of Medicine, Seattle, Washington, USA.
⁴ Cardiology, University of Louisville, Louisville, Kentucky, USA dinesh.kalra@louisville.edu.

PMID: 37918900
DOI: 10.1136/heartjnl-2023-322928

Review

Atherosclerotic cardiovascular disease risk prediction: current state-of-the-art

Amit Rout et al. Heart. 2024.

. 2024 Jul 10;110(15):1005-1014.

doi: 10.1136/heartjnl-2023-322928.

Authors

Amit Rout¹, Sanchit Duhan², Muhammad Umer¹, Miranda Li³, Dinesh Kalra⁴

Affiliations

¹ Cardiology, University of Louisville, Louisville, Kentucky, USA.
² Cardiology, Sinai Health System, Baltimore, Maryland, USA.
³ Cardiology, University of Washington School of Medicine, Seattle, Washington, USA.
⁴ Cardiology, University of Louisville, Louisville, Kentucky, USA dinesh.kalra@louisville.edu.

PMID: 37918900
DOI: 10.1136/heartjnl-2023-322928

No abstract available

Keywords: atherosclerosis; biomarkers; coronary artery disease; hyperlipidemias; risk factors.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

Next-Generation Primary Atherosclerotic Cardiovascular Risk Prediction Tool. Are Nonmodifiable Risk Factors Relevant in the Equation?
Yeboah J. Yeboah J. Am J Cardiol. 2020 Dec 15;137:132-133. doi: 10.1016/j.amjcard.2020.10.003. Epub 2020 Oct 9. Am J Cardiol. 2020. PMID: 33045204 No abstract available.
A Risk Prediction Model of Atherosclerotic Cardiovascular Disease in Japan.
Saito I. Saito I. J Atheroscler Thromb. 2022 Mar 1;29(3):320-321. doi: 10.5551/jat.ED172. Epub 2021 May 16. J Atheroscler Thromb. 2022. PMID: 33994404 Free PMC article. No abstract available.
High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes.
Tang O, Matsushita K, Coresh J, Ndumele C, McEvoy JW, Sharrett AR, Hoogeveen R, Ballantyne CM, Selvin E. Tang O, et al. Diabetes Care. 2020 Oct;43(10):e144-e146. doi: 10.2337/dc20-1312. Epub 2020 Aug 11. Diabetes Care. 2020. PMID: 32788284 Free PMC article. No abstract available.
Breast Arterial Calcification: A Potential Biomarker for Atherosclerotic Cardiovascular Disease Risk?
Yoon YE, Yun B, Kim KM, Suh JW. Yoon YE, et al. Curr Atheroscler Rep. 2021 Mar 26;23(5):21. doi: 10.1007/s11883-021-00924-5. Curr Atheroscler Rep. 2021. PMID: 33772359 Review.
Prediction and early detection of cardiovascular disease in South Asians with diabetes mellitus.
Wander GS, Bansal M, Kasliwal RR. Wander GS, et al. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):385-393. doi: 10.1016/j.dsx.2020.04.017. Epub 2020 Apr 17. Diabetes Metab Syndr. 2020. PMID: 32334394 Review.

See all similar articles

Cited by

Global, regional, and national burden of cardiovascular diseases attributable to metabolic risks across all age groups from 1990 to 2021: an analysis of the 2021 global burden of disease study data.
Zhu XY, Shi MQ, Jiang ZM, Xiao-Li, Tian JW, Su FF. Zhu XY, et al. BMC Public Health. 2025 May 8;25(1):1704. doi: 10.1186/s12889-025-22702-7. BMC Public Health. 2025. PMID: 40340811 Free PMC article.
Plant-Derived as Alternatives to Animal-Derived Bioactive Peptides: A Review of the Preparation, Bioactivities, Structure-Activity Relationships, and Applications in Chronic Diseases.
Sun L, Liu J, He Z, Du R. Sun L, et al. Nutrients. 2024 Sep 27;16(19):3277. doi: 10.3390/nu16193277. Nutrients. 2024. PMID: 39408244 Free PMC article. Review.
SHR-1918, A Monoclonal Antibody Against Angiopoietin-Like 3, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Study.
Qin R, Ye L, Duan L, Li M, He W, Mei X, Li D, Jin R, Lv C, Zhu M, Wang S, Xie Z. Qin R, et al. Clin Pharmacokinet. 2025 Aug;64(8):1245-1253. doi: 10.1007/s40262-025-01539-8. Epub 2025 Jun 27. Clin Pharmacokinet. 2025. PMID: 40576753 Clinical Trial.
Current approach to atherosclerotic cardiovascular disease risk prediction.
Khan WJ, Kalra DK. Khan WJ, et al. Future Cardiol. 2025 Feb;21(2):67-69. doi: 10.1080/14796678.2024.2433349. Epub 2024 Nov 24. Future Cardiol. 2025. PMID: 39580639 No abstract available.
The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes.
Gounden V, Devaraj S, Jialal I. Gounden V, et al. Lipids Health Dis. 2024 Dec 23;23(1):416. doi: 10.1186/s12944-024-02412-6. Lipids Health Dis. 2024. PMID: 39716258 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information